Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Cash from Operations (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Cash from Operations readings, the most recent being 388400000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 60.16% to 388400000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 782700000.0, a 31.46% increase, with the full-year FY2025 number at 782700000.0, up 31.46% from a year prior.
  • Cash from Operations hit 388400000.0 in Q4 2025 for Neurocrine Biosciences, up from 227500000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 388400000.0 in Q4 2025 to a low of 125200000.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 113350000.0 (2021), compared with a mean of 118195000.0.
  • Biggest five-year swings in Cash from Operations: surged 3304.76% in 2022 and later crashed 209.14% in 2023.
  • Neurocrine Biosciences' Cash from Operations stood at 4200000.0 in 2021, then surged by 3304.76% to 143000000.0 in 2022, then dropped by 13.64% to 123500000.0 in 2023, then skyrocketed by 96.36% to 242500000.0 in 2024, then soared by 60.16% to 388400000.0 in 2025.
  • The last three reported values for Cash from Operations were 388400000.0 (Q4 2025), 227500000.0 (Q3 2025), and 102000000.0 (Q2 2025) per Business Quant data.